Latest News

  • TECHNOLOGY

    18 Feb 2026

    How the Cloud Powers the Next mRNA Breakthrough

  • INSIGHTS

    16 Feb 2026

    Can Europe Win the mRNA Cancer Race?

  • REGULATORY

    12 Feb 2026

    FDA Refusal-to-File Resets mRNA Flu Strategy

  • INNOVATION

    11 Feb 2026

    Britain’s Bet On Better RNA Factories

Moderna and Recordati Bet on mRNA Beyond Vaccines

Syringe labeled Moderna mRNA-3927 with Recordati logo in background

PARTNERSHIPS

10 Feb 2026

Moderna and Recordati partner on an mRNA therapy for propionic acidemia, combining resources to accelerate development

mRNA vaccine vial illustration symbolizing the industry’s expansion into rare-disease therapies

INSIGHTS

6 Aug 2025

The Rare-Disease Frontier Where mRNA Is Headed

Acuitas pioneers gene-editing delivery for rare disease, signaling mRNA's evolution beyond vaccines.

Colorful RNA sequence and helix graphic showing AI-driven mRNA design innovation

TECHNOLOGY

29 Jul 2025

Smarter, Faster, Cheaper: Al Reinvents mRNA Discovery

UT Austin and Sanofi unveil RiboNN, an Al that speeds mRNA drug development and raises early-stage success rates.

3D DNA and RNA strands illustrating emerging in-vivo CAR-T and RNA therapy innovations

INNOVATION

25 Jul 2025

RNA Therapy Makes CAR-T in the Body a Reality

Orbital's circular RNA reprograms CAR-T cells in vivo, cutting costs and widening access for autoimmune and cancer care.

FDA vaccine fact sheets for Pfizer, Moderna, and Janssen showing updated safety guidance

REGULATORY

27 Jun 2025

FDA Tightens Rules on Pfizer and Moderna Shots

New FDA rules force Moderna and Pfizer to add clearer heart warnings to mRNA vaccine labels.

Thermo Fisher Scientific building exterior representing mRNA partnership expansion

PARTNERSHIPS

15 Jun 2025

mRNA Momentum Builds as Ethris and Thermo Fisher Join Forces

New alliance solves key mRNA production barriers, speeding Ethris's SNIM RNA therapies like lead nasal spray candidate ETH47 toward market...

Pfizer and Moderna COVID vaccine vials with syringe highlighting evolving vaccine market trends

MARKET TRENDS

6 Jun 2025

As COVID Demand Shrinks, Vaccine Makers Rethink Their Strategy

With tighter rules and a smaller market, mRNA leaders refocus on high-risk groups and aim to sharpen delivery and messaging.

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.